Advaita Bioinformatics is a leader in the interpretation of high-throughput biomedical data including variant interpretation, pathway analysis, disease subtype discovery
We're Celebrating a Birthday and You're Invited
We're giving away a 1 year subscription to iVariantGuide. All you need to do is log in to iVariantGuide and analyze a new VCF.
Every user who analyzes a VCF between April 7th and May 7th will be entered to win. See how to create new iVariantGuide analyses in this short video.
On February 27, 2017, Advaita released a major updates to its platform. These are teh release notes.
IMPROVEMENTS TO: iPathwayGuide, iVariantGuide, iBioguide, and the Advaita Knowledge Base
IMPROVEMENTS TO iPATHWAYGUIDE
On February 17, 2017, we found out about Cloudbleed, a major leak of user data affecting several sites and services that use infrastructure provided by Cloudflare. As part of Advaita’s commitment to offering a HIPAA compliant secure informatics platform, we wanted you to know that the Advaita Cloud Solution Platform (including iPathwayGuide, iVariantGuide, and iBioGuide) does not use services from Cloudflare and has NOT been impacted by this incident and NO Advaita user data has been leaked.
Some other bioinformatics service providers seem to have been impacted by the Cloudflare security issue (e.g. 23andMe, Qiagenbioinformatics, etc.). We encourage you to investigate if any of your other service providers are potentially affected by Cloudflare. Here are a couple resource to check:
http://www.doesitusecloudflare.com/ (enter a domain URL)
https://cloudbleed.github.io/ (Checks your browser's cache for limited # of known affected sites)
If you have any questions about your Advaita account, please do not hesitate to contact our customer support team at: firstname.lastname@example.org
The Advaita Security Team
No current openings.
Advaita Bio's iPathwayGuide was chosen after a lengthy evaluation to be a side-wide solutions provider for the analysis of mRNA and protein expression data for all researchers attached to the National Cancer Institute (NCI). Its ease of use, advance analytic capabilities, and price point were all factors in its selection.
Advaita Bioinformatics has been recognized as one of the 2016 “Michigan 50 Companies to Watch,” an awards program presented by Michigan Celebrates Small Business.
Advaita will be honored at an awards ceremony during the twelfth annual Michigan Celebrates Small Business gala event, May 5, 2016 in Lansing, Mich.
SCIEX Announces US HUPO Workshop: New Innovations Towards Industrialized Proteomics
SCIEX Seminars Will Focus on Using Industrialized Omics to Perform the Translational Research Needed to Enable Precision Medicine
In response to numerous requests to expand our already flexible pricing and licensing model, we have introduced a new 30-day subscription plan. The subscription plan is ideally suited for smaller, low-throughput labs that don't generate enough data to justify purchasing an annual license.
The new subscription plan is only available by credit card purchase and takes immediate effect upon purchase. During the 30-day period the purchaser can analyze as many datasets as needed and all feature are unlock including downloading and meta-analysis functions.
Pricing for the new plan was announced at $995, but has an introductory price of just $595. When asked about the new pricing plan,Advaita's iPathwayGuide Product Manager, Sidra Ahsan, Ph.D. said, "We are very excited to offer this new pricing plan. Many researchers have asked for an even more flexible pricing plan and we think this fits that need. No other bioinformatics company offers this type of flexible plan with best-in-class features like iPathwayGuide."
The new plan started February 1, 2016 and the promotional pricing is expected to extend until at least until May 1, 2016.